BackTable / Tumor Board / Podcast / Episode #31

NMIBC Tumor Board: Upper Tract Challenges

with Dr. Mark Tyson and Dr. Sarah Psutka

One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder and the ureter? In the final episode of the 2025 NMIBC Creator Weekend™ series, Dr. Vignesh Packiam, Dr. Mark Tyson and Dr. Sarah Psutka share how they approach complex bladder cancer cases with upper tract involvement.

This podcast is supported by:

Ferring Pharmaceuticals

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Tumor Board Podcast

Ep 31 NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka

00:00 / 01:04

BackTable, LLC (Producer). (2025, October 7). Ep. 31 – NMIBC Tumor Board: Upper Tract Challenges [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Vignesh Packiam

Dr. Vignesh Packiam is an associate professor of urologic oncology at Rutgers Cancer Institute of New Jersey.

Dr. Sarah Psutka

Dr. Sarah Psutka is a urologic oncologist and associate professor at University of Washington in Seattle.

Dr. Mark Tyson

Dr. Mark Tyson is a urologic oncologist and professor of urology with Mayo Clinic in Scottsdale, Arizona.

Synopsis

The doctors discuss complex bladder cancer cases, sequencing treatments for patients with dual ureteral and bladder T1 disease, the impact of cystectomy on quality of life, and the use of blue light cystoscopy and intravesical therapy. They also delve into the rise of bladder cancer in younger patients, considerations for low-grade intermediate-risk disease, and emerging therapeutic options.

Timestamps

00:00 - Introduction
05:52 - Upper Tract Positive Cytology Dilemma
09:10 - Cystectomy Considerations
15:55 - Developing Better Patient-Reported Outcomes
20:26 - Challenges with New Therapeutics
26:31 - Deescalating Treatment for Low-Grade Cancer
33:29 - Closing Remarks

Resources

CISTO Trial
https://pubmed.ncbi.nlm.nih.gov/37980511/

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast

Keynote-689: Implementation & Multidisciplinary Care for Immunotherapy in Head & Neck Cancer with Dr. Adam Luginbuhl, Dr. Jennifer Johnson, Dr. Mihir Patel and Dr. Siddharth Sheth on the BackTable Tumor Board Podcast

Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.